5889.T
The company operates in the healthcare services and equipment industry, primarily generating revenue through the sale of medical equipment, supplies, and distribution services.
Business. 5889.T is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not available in the provided data.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
5889.T is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not available in the provided data.
The company maintains a market price of 2167.0 JPY, with a market capitalization of 52,886,025,060.0 JPY, indicating a moderate valuation relative to its equity and tangible book value. The price-to-earnings ratio of 13.98 and a price-to-book ratio of 2.91 suggest the company is trading at a premium to its book value but at a reasonable multiple of earnings. The company's liquidity position is characterized by a current ratio of 0.44, which is below 1, indicating potential short-term liquidity constraints. The company's free cash flow of 2,822,000,000.0 JPY supports its operations and provides flexibility for reinvestment or shareholder returns.
Profitability metrics show a return on equity of 20.8% and a return on assets of 9.48%, both of which are strong indicators of efficient capital utilization and asset management. The company's operating income of 5,957,000,000.0 JPY and net income of 3,783,000,000.0 JPY reflect a healthy margin structure, with a gross profit of 14,672,000,000.0 JPY supporting these results. The debt-to-equity ratio of 0.86 suggests a balanced capital structure, with long-term debt of 15,604,000,000.0 JPY and total equity of 18,187,000,000.0 JPY.
The company's revenue of 18,640,000,000.0 JPY is derived from its core operations in the healthcare services and equipment industry, with no disclosed segment or geographic breakdown provided in the available data. The absence of detailed segment or geographic data limits the ability to assess revenue concentration or diversification.
The company's growth trajectory is supported by a free cash flow of 2,822,000,000.0 JPY and a capital expenditure of -721,000,000.0 JPY, indicating a net outflow for investment in operations. Analyst estimates suggest a mean recommendation of 2.00, with one buy rating and no strong buy or sell ratings, indicating a neutral to slightly positive outlook. The mean EPS estimate of 205.90 JPY is higher than the last actual EPS of 156.81 JPY, suggesting potential for earnings growth.
The company's risk profile is characterized by a medium liquidity risk and a low dilution risk, with key flags indicating that net cash is negative after subtracting total debt. The company's capital structure includes long-term debt of 15,604,000,000.0 JPY and total liabilities of 21,724,000,000.0 JPY, with total assets of 39,911,000,000.0 JPY. The absence of detailed risk factors or dilution sources in the available data limits the ability to assess specific risk drivers.
Recent events and filings are not detailed in the available data, limiting the ability to assess the company's recent performance or strategic initiatives. The company's financial performance and risk profile suggest a stable but moderate growth outlook, with a focus on maintaining liquidity and managing debt levels.
- The company has a strong return on equity of 20.8%, indicating efficient use of shareholder capital.
- The company's liquidity position is constrained, with a current ratio of 0.44, suggesting potential short-term financial stress.
- The company's debt-to-equity ratio of 0.86 indicates a balanced capital structure, with manageable leverage.
- Analysts have a neutral to slightly positive outlook, with a mean recommendation of 2.00 and one buy rating.
- The company's free cash flow of 2,822,000,000.0 JPY provides flexibility for reinvestment or shareholder returns.
- The company's risk profile is characterized by medium liquidity risk and low dilution risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 205,90 |
| Revenue | —no estimate | —no estimate | 22,6B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 5889.T Market data — financials · 2026-05-26
- Japan Eyewear Holdings Co Ltd Market data — analyst estimates · 2026-05-26